Targeted liposomal drug delivery in cancer

Current Pharmaceutical Design
Oula Penate MedinaKalevi Kairemo

Abstract

Liposomes, which are biodegradable and essentially non-toxic vehicles, can encapsulate both hydrophilic and hydrophobic materials, and are utilized as drug carriers in drug delivery systems. In addition, liposomes can be used to carry radioactive compounds as radiotracers can be linked to multiple locations in liposomes. One option is the hydrated compartment inside the liposome, another the lipid core into which especially hydrophobic conjugates can be attached, and the third option is the outer lipid leaflet where molecules can be bound by covalent linkage. Delivery of agents to the reticuloendothelial system (RES) is easily achieved, since most conventional liposomes are trapped by the RES. For the purpose of delivery of agents to target organs other than RES, long-circulating liposomes have been developed by modifying the liposomal surface. Understanding of the in vivo dynamics of liposome-carried agents is required for the evaluation of the bioavailability of drugs encapsulated in liposomes. In this review, we focus on the in vivo trafficking of liposomes visualized by positron emission tomography (PET) and discuss the characteristics of liposomes that affect the targeting of drugs in vivo.

Citations

Feb 9, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Luis A MedinaMaría-Ester Brandan
Mar 19, 2013·International Journal of Pharmaceutics·Kacoli Sen, Mahitosh Mandal
Nov 11, 2008·Bioconjugate Chemistry·Jai Woong SeoKatherine W Ferrara
Jul 17, 2009·Journal of the American Chemical Society·Gary J TongMatthew B Francis
Dec 1, 2006·The Journal of Physical Chemistry. B·Christopher L KuyperDaniel T Chiu
Apr 15, 2011·Journal of Drug Delivery·Maluta S MufamadiValence M K Ndesendo
Apr 5, 2008·BMC Biotechnology·Hagit BarItai Benhar
Feb 16, 2006·Journal of Nanobiotechnology·Pratik SinghMarianne Manchester
Mar 15, 2012·The AAPS Journal·Rupa R Sawant, Vladimir P Torchilin
Aug 6, 2014·Drug Design, Development and Therapy·Blenda Chi Kwan WongZhijun Yang
Jul 28, 2012·Therapeutic Delivery·Carola HeneweerOula Peñate-Medina
Dec 4, 2013·Future Oncology·Emanuela GentileChristian Celia
Mar 25, 2011·Journal of Materials Science. Materials in Medicine·Felicity de CoganSimon J Webb
Sep 16, 2014·Annales pharmaceutiques françaises·R Ouvinha de OliveiraG Barratt
Jan 4, 2012·Drug Delivery·Mine SilindirSuna Erdoğan
Nov 22, 2005·Expert Opinion on Drug Delivery·Bin ChenTayyaba Hasan
Jan 19, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jai Woong SeoKatherine W Ferrara
Nov 5, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Oula Penate MedinaSteven M Larson
May 25, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yu-Lan HuJian-Qing Gao
May 13, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Di-Cai LiYan-Xiang Gao
Apr 15, 2011·Journal of Drug Delivery·Oula Penate MedinaKalevi Kairemo
May 22, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Pratik SinghMarianne Manchester
Nov 6, 2013·International Immunopharmacology·Xiaojuan ZhaoCui Liu
Apr 2, 2016·Pharmaceutical Research·M Luísa CorvoAlexandra R Fernandes
Apr 4, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Max KullbergThomas J Anchordoquy
Oct 1, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yu ZhangRichard A Gemeinhart
Oct 19, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amit AlexanderShailendra Saraf
Nov 5, 2016·International Journal of Pharmaceutics·Vivienne H TamRodney D Priestley
Jan 6, 2006·Chemical & Pharmaceutical Bulletin·Yoshiyuki HagiwaraKaneto Uekama
Apr 6, 2012·Technology in Cancer Research & Treatment·J Zhong, L C Dai
Sep 29, 2011·Pharmaceutics·Sachin PatelVyomesh Patel
Jan 12, 2013·International Journal of Molecular Sciences·Sanshiro HanadaKenji Yamamoto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.